Search
Search Results
-
-
-
Neoadjuvante und adjuvante Therapie beim Pankreaskarzinom
BackgroundResection is the only curative treatment option for pancreatic cancer patients. Adjuvant chemotherapy can improve disease-free survival and...
-
Chirurgie bei isoliertem Lokalrezidiv und metachroner Oligometastasierung beim Pankreaskarzinom
BackgroundMost patients with pancreatic cancer suffer a relapse, which occurs either locally or systemically in the sense of liver and the lung...
-
Molekulare Prädiktoren für den Krankheitsverlauf und die individualisierte Therapie beim Pankreaskarzinom
The understanding of the development of pancreatic cancer has undergone considerable development over the last two decades. This is mainly due to the...
-
-
Rolle der Radiotherapie beim Pankreaskarzinom
BackgroundPancreatic cancer is a tumor with a worldwide incidence of approximately 340,000 newly diagnosed patients per year. With a 5-year overall...
-
Neoadjuvante Therapie beim primär resektablen und Borderline-resektablen Pankreaskarzinom
Due to the increasing prevalence pancreatic cancer represents a severe tumor burden to the population and will be ranked second for cancer-related...
-
-
-
-
Ablative Therapieoptionen beim lokal fortgeschrittenen, irresektablen und grenzwertig resektablen Pankreaskarzinom
BackgroundLocally advanced unresectable (nonmetastatic) and borderline resectable pancreatic carcinomas represent a therapeutic challenge. Several...